MKI67 and cancer: Figure 2B exhibited that the MKI67 expression was upregulated among diverse cancer types consistent with the results of the TIMER2 dataset. We further evaluated MKI67 protein levels between pan-cancer and adjacent normal tissues using the CPTAC dataset in transcriptional levels. Figure 2C indicated MKI67 protein expression was significantly higher among COAD, BRCA, LIHC, LUAD, PAAD, and OV consistent with TIMER2 database and TCGA data.